Delivery Order SPE2DB25D3012-SPE2DB25FWZAE
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,290.30 on September 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product with a ceiling value of $3,659.10. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order is scheduled...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Menveo vaccine (5-dose vials) with a ceiling value of $10,748.79. This firm fixed-price delivery order, with a completion date of June 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-diphtheria), 0.5 mL. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,159.30 and is scheduled for completion by August 13, 2025. The award is issued under a non-set-aside procurement and represents a child contract action...
- The Defense Logistics Agency awarded a $5,868.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work is to be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo vaccine (5-dose vials) with a ceiling value of $33,937.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025....